Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.500
+0.120 (5.04%)
At close: Mar 9, 2026, 4:00 PM EDT
2.520
+0.020 (0.80%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Sonoma Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
--3.133.827.44.22
Cash & Short-Term Investments
--3.133.827.44.22
Cash Growth
---18.12%-48.35%75.26%14.33%
Accounts Receivable
--2.92.572.412.81
Inventory
--2.722.862.662.53
Other Current Assets
0.150.213.84.553.963.43
Total Current Assets
0.150.2112.5513.816.4312.98
Net Property, Plant & Equipment
0.960.310.650.910.881.13
Other Long-Term Assets
0.520.741.541.531.540.88
Total Assets
13.6213.6914.7416.2318.8514.99
Accounts Payable
--0.610.841.641.77
Accrued Expenses
--2.112.031.841.15
Short-Term Debt
-0.220.320.430.690.6
Current Portion of Long-Term Debt
----0.12-
Current Portion of Leases
0.150.060.20.260.250.24
Unearned Revenue
--0.480.161.280.32
Total Current Liabilities
0.150.283.723.725.824.08
Long-Term Debt
-----1.31
Long-Term Leases
0.510.030.090.160.310.53
Other Long-Term Liabilities
5.475.164.84.384.023.71
Total Long-Term Liabilities
5.975.194.884.544.335.55
Total Liabilities
10.199.288.68.2510.159.62
Common Stock
---0.0100
Additional Paid-in Capital
207.02206.59203.21200.9197.37189.22
Accumulated Other Comprehensive Income
-3.19-4.38-2.72-3.42-4.31-4.58
Retained Earnings
-200.4-197.81-194.35-189.51-184.36-179.28
Shareholders' Equity
3.434.416.147.988.75.36
Total Liabilities & Equity
13.6213.6914.7416.2318.8514.99
Total Debt
0.660.310.610.851.372.68
Net Cash (Debt)
-0.66-0.312.522.976.031.55
Net Cash Growth
---15.18%-50.72%290.23%-45.62%
Net Cash Per Share
-0.40-0.255.5417.5145.4515.48
Book Value
3.434.416.147.988.75.36
Book Value Per Share
2.083.5513.4947.0165.5653.74
Tangible Book Value
3.434.416.147.988.75.36
Tangible Book Value Per Share
2.083.5513.4947.0165.5653.74
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q